Deciphering the Selectivity of CBL-B Inhibitors Using All-Atom Molecular Dynamics and Machine Learning
Feng Zhou1, Haolin Du1, Yang Wang1
1Beijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, Beijing 100080, China.
ACS Medicinal Chemistry Letters
|July 17, 2024
Summary
This study uses molecular dynamics and machine learning to understand how CBL-B and C-CBL proteins bind to ligands. Key amino acids were identified, guiding the design of more selective drugs.
Area of Science:
- Biochemistry
- Computational Biology
- Pharmacology
Background:
- CBL-B and C-CBL are related proteins with distinct binding properties.
- Understanding their ligand interactions is crucial for drug discovery.
Purpose of the Study:
- To elucidate the dynamic characteristics governing CBL-B and C-CBL binding affinity and selectivity.
- To identify key molecular determinants of ligand interactions and dissociation pathways.
Main Methods:
- Accelerated molecular dynamics simulations.
- Machine learning models for predicting dissociation rate constants (koff).
- Molecular mechanics with generalized Born and surface area solvation (MM/GBSA) for binding free energy calculations.
Main Results:
- A predictive model for koff showed moderate correlation with experimental IC50 values.
- Key amino acids in binding pockets and dissociation pathways were identified as crucial for activity and selectivity.
- Statistically significant amino acids contribute to structural differences between CBL-B and C-CBL.
- MM/GBSA calculations revealed significant binding free energy differences (ΔG) between the two proteins.
Conclusions:
- The study successfully identified key amino acids responsible for the differential binding of CBL-B and C-CBL.
- Predicted koff values and identified amino acids offer valuable insights for designing highly selective drugs.
- The combined computational approach provides a robust framework for understanding protein-ligand interactions.
